Joseph Shulman
Chief Tech/Sci/R&D Officer bij RHYTHM PHARMACEUTICALS, INC.
Vermogen: 1 300 $ op 31-03-2024
Profiel
Joseph Shulman's current job is Chief Technical Officer at Rhythm Pharmaceuticals, Inc. His former jobs include Senior Vice President-Technical Operations at Ra Pharmaceuticals, Inc. and Senior Vice President-Global Technical Operations at Novelion Therapeutics, Inc. He holds an MBA from Boston University and an undergraduate degree from the University of Miami.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
21-03-2024 | 30 ( 0.00% ) | 1 300 $ | 31-03-2024 |
Actieve functies van Joseph Shulman
Bedrijven | Functie | Begin |
---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 27-07-2020 |
Eerdere bekende functies van Joseph Shulman
Bedrijven | Functie | Einde |
---|---|---|
RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-07-2020 |
NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-07-2019 |
Opleiding van Joseph Shulman
Boston University | Masters Business Admin |
University of Miami | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |